NEW YORK, Nov. 2, 2016 /PRNewswire/ -- Prospects for Companies in Original-Branded and Generic Drug Distribution; Profiles, Performance and Revenue Forecasting of Leading Wholesalers in the US, Europe, Japan and China, including McKesson, Cardinal Health, AmerisourceBergen, Walgreens Boots Alliance, MEDIPAL, PHOENIX Group, SINOPHARM and Suzuken Report Details Pharma Wholesaling and Distribution - Analysis of Companies, Trends and Future Revenues to Benefit Your InfluenceWhat does the future hold for drug wholesale and distribution (W&D) services? Discover revenue predictions there to 2026. And explore trends in those services and technologies, assessing prospects and finding opportunities to benefit your work and authority.In visiongain's new report you gain revenue forecasts at overall world market, submarket, company and national level. There you assess potentials for expanding revenues. See where that industry's best prospects lie.Please read on to explore activities of distributors and wholesalers of pharmaceuticals, discovering what that business's future could be worth. Forecasts and other analysis to benefit your knowledge of medical distribution systemsIs finding pharma wholesale and distribution information a challenge? Avoid falling behind in knowledge on the supply of medicines. With our data, help your research, analyses and decisions. Also save time and benefit your reputation for commercial insight.Besides revenue forecasting, our new investigation shows historical data, growth rates and market shares. That industry changes in 2016 through mergers and acquisitions. In our study discover what is happening, helping you stay ahead.There you find original quantitative and qualitative analyses, exploring business outlooks and developments. In our 272 page study you gain 83 tables, 98 charts and a research interview.Discover where revenues can increase most. In the following sections you see how our new study benefits your knowledge on the supply chain for human medicines. Prospects for that world market and submarkets - discover what revenues are possibleOur new report shows revenue to 2026 for the overall world market. It also gives you forecasts for three submarkets in the distributing and wholesaling of medicines:• Original-branded pharmaceuticals - small molecules and biological drugs• Generic prescription medicines - generics• Other products related to pharmaceutical supply.Discover pharma distribution chain revenues. How will that wholesaling and distributing market grow? Which parts will prosper most, and why? With our data you assess potential sales and revenue growth. See what is possible from 2016.In our study you also discover geographical revenue predictions.Sales potentials for medical wholesaling and distributing in leading countriesDevelopments worldwide expand the pharma W&D market, especially rising demand for medicines in fast-emerging countries. China, India, Russia and Brazil underpin revenue growth. Discover how domestic and international suppliers expand business.In developed and developing regions opportunities for drug wholesalers and other medical suppliers will occur from 2016. Pharmacies also stand to gain. See where, why and how, discovering what is possible.